Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial
Titel:
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial
Auteur:
Cole, Peter D McCarten, Kathleen M Pei, Qinglin Spira, Menachem Metzger, Monika L Drachtman, Richard A Horton, Terzah M Bush, Rizvan Blaney, Susan M Weigel, Brenda J Kelly, Kara M